Drug co-developed by Mass. company slows Alzheimer's, researchers say

An experimental Alzheimer's drug co-developed by Cambridge-based Biogen slowed the brain disease's inevitable worsening, researchers reported.

Related Keywords

United States ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,San Francisco ,California ,Japanese ,Americans ,Ron Petersen ,Maria Carrillo ,Mayo Petersen ,Madhav Thambisetty ,Michael Irizarry ,Science Department ,National Institute On ,Drug Administration ,Christopher Van Dyck At Yale University ,Associated Press ,Alzheimer Association We ,New England Journal ,January Every ,National Institute ,Mayo Clinic ,Associated Press Health ,Howard Hughes Medical Institute ,5 On Your Health ,Alzheimer 039s Drug ,Biogen ,Oston News ,Ambridge Company ,Cvb ,Rug Slows Alzheimer 039 S ,Lecanemab ,